Research
Hormonal
Tirzepatide improves hepatic steatosis and renal outcomes in patients with type 2 diabetes, independent of or additive to weight loss.
Tirzepatide not only helps with blood sugar and weight but also significantly reduces liver fat and protects kidney function in people with type 2 diabetes. This makes it a valuable option for those at risk of liver or kidney complications.
GoodSupportsHIGH confidence
The absolute difference in liver fat content [LFC] was − 4.7% (95% CI from − 6.7 to − 2.7), with a relative decrease in LFC from baseline of − 35.9% and − 28.4% for the two individual dosages (p < 0.0005)... The composite renal outcome (ESRD, eGFR decline > 40%, renal death, new onset of macroalbuminuria) strongly favored tirzepatide (HR 0.58, 95% CI from 0.43 to 0.80, p = 0.0008)
Why this rating
Based on post-hoc analyses of phase 3 trials (SURPASS-3, SURPASS-4).
Source
GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes
Stefano Ciardullo et al. · Acta Diabetologica · 2024
DOI 10.1007/s00592-024-02300-6
narrative_reviewCited 12×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →